A detailed history of Apg Asset Management N.V. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Apg Asset Management N.V. holds 21,771 shares of REGN stock, worth $15.6 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
21,771
Previous 127,424 82.91%
Holding current value
$15.6 Million
Previous $134 Million 82.91%
% of portfolio
0.15%
Previous 0.23%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1024.09 - $1201.76 $108 Million - $127 Million
-105,653 Reduced 82.91%
21,771 $22.9 Million
Q2 2024

Aug 14, 2024

SELL
$883.2 - $1071.19 $14.4 Million - $17.5 Million
-16,343 Reduced 11.37%
127,424 $134 Million
Q1 2024

May 14, 2024

SELL
$902.69 - $993.35 $2.53 Million - $2.79 Million
-2,807 Reduced 1.92%
143,767 $138 Million
Q4 2023

Feb 13, 2024

BUY
$775.18 - $881.7 $2.39 Million - $2.71 Million
3,077 Added 2.14%
146,574 $129 Million
Q3 2023

Nov 14, 2023

SELL
$692.45 - $844.37 $2.22 Million - $2.71 Million
-3,207 Reduced 2.19%
143,497 $118 Million
Q2 2023

Aug 14, 2023

SELL
$700.03 - $830.35 $4.34 Million - $5.15 Million
-6,205 Reduced 4.06%
146,704 $105 Million
Q1 2023

May 12, 2023

SELL
$680.49 - $826.97 $16.7 Million - $20.3 Million
-24,551 Reduced 13.83%
152,909 $126 Million
Q4 2022

Feb 14, 2023

BUY
$705.89 - $766.39 $13.3 Million - $14.5 Million
18,869 Added 11.9%
177,460 $128 Million
Q3 2022

Nov 14, 2022

SELL
$573.97 - $724.32 $53.2 Million - $67.2 Million
-92,715 Reduced 36.89%
158,591 $112 Million
Q2 2022

Aug 12, 2022

SELL
$548.35 - $738.84 $67.6 Million - $91.1 Million
-123,289 Reduced 32.91%
251,306 $142 Million
Q1 2022

May 12, 2022

SELL
$595.12 - $698.43 $19.7 Million - $23.1 Million
-33,029 Reduced 8.1%
374,595 $235 Million
Q4 2021

Feb 11, 2022

SELL
$543.48 - $670.97 $4.46 Million - $5.5 Million
-8,200 Reduced 1.97%
407,624 $226 Million
Q3 2021

Nov 15, 2021

SELL
$574.03 - $680.96 $4.71 Million - $5.58 Million
-8,200 Reduced 1.93%
415,824 $217 Million
Q2 2021

Aug 13, 2021

SELL
$472.8 - $558.54 $414,645 - $489,839
-877 Reduced 0.21%
424,024 $200 Million
Q1 2021

May 14, 2021

SELL
$446.73 - $548.2 $14.1 Million - $17.3 Million
-31,568 Reduced 6.92%
424,901 $171 Million
Q4 2020

Feb 12, 2021

BUY
$478.3 - $607.98 $55.3 Million - $70.3 Million
115,711 Added 33.96%
456,469 $180 Million
Q3 2020

Nov 12, 2020

BUY
$544.75 - $658.21 $13.3 Million - $16.1 Million
24,500 Added 7.75%
340,758 $163 Million
Q2 2020

Aug 14, 2020

BUY
$493.32 - $643.92 $130 Million - $170 Million
264,471 Added 510.69%
316,258 $176 Million
Q1 2020

May 15, 2020

SELL
$336.18 - $494.43 $32.8 Million - $48.2 Million
-97,495 Reduced 65.31%
51,787 $25.3 Million
Q1 2020

May 14, 2020

BUY
$336.18 - $494.43 $40 Million - $58.8 Million
118,872 Added 390.9%
149,282 $54.6 Million
Q4 2019

Feb 13, 2020

BUY
$274.13 - $376.51 $1.63 Million - $2.24 Million
5,950 Added 24.33%
30,410 $10.2 Million
Q3 2019

Nov 08, 2019

SELL
$273.46 - $318.39 $34.2 Million - $39.8 Million
-124,922 Reduced 83.63%
24,460 $6.22 Million
Q2 2019

Aug 13, 2019

BUY
$299.6 - $414.82 $29,960 - $41,482
100 Added 0.07%
149,382 $41.1 Million
Q1 2019

May 14, 2019

BUY
$372.08 - $439.57 $48.7 Million - $57.5 Million
130,900 Added 712.11%
149,282 $54.6 Million
Q4 2018

Feb 13, 2019

SELL
$335.82 - $403.04 $67,164 - $80,608
-200 Reduced 1.08%
18,382 $6.01 Million
Q4 2017

Jan 24, 2018

SELL
$358.63 - $469.95 $851,746 - $1.12 Million
-2,375 Reduced 11.33%
18,582 $5.82 Million
Q3 2017

Oct 19, 2017

BUY
$431.38 - $504.0 $9.04 Million - $10.6 Million
20,957
20,957 $9.37 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Apg Asset Management N.V. Portfolio

Follow Apg Asset Management N.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management N.V. with notifications on news.